BRACE Award Venture Competition

17 September 2021

The Asian Fund for Cancer Research (AFCR) congratulates our six semi-finalists of the 2021 BRACE Award Venture Competition. After the virtual competition on 17 September 2021, one winning business will receive the equivalent of US$300,000 in equity investment funding from AFCR, subject to due diligence and negotiation, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for early-stage oncology start-ups that are creating life-saving innovations!

In addition to the winner selected by the Judging Committee, the BRACE Award Venture Competition is looking to name one of our semi-finalists as the “Best Public Communicator”. AFCR wishes to increase the visibility of our semi-finalists, spread the word about their innovative technologies and help highlight their marketing skills. The Best Public Communicator will be awarded HK$5,000.

Lynda Chin, M.D.

Chief Executive Officer

Apricity Logo

Bee Hui Liu, Ph.D.



Gus Zeiner, Ph.D.


Chimera Bio

Edward Kai-Hua Chow, Ph.D.



Huren Sivaraj, M.D.

Co-Founder & Chief Executive Officer

Chuanhua (Julia) Xing, Ph.D.

Chief Executive Officer

Shi Hua Med

Supporters & Sponsors

Vote submission e-mail addresses will be added to the Asian Fund for Cancer Research’s general communication recipient list. These e-mail addresses will NEVER be sold, rented or otherwise conveyed to any other organization except only the National Foundation for Cancer Research and AIM-HI Accelerator Fund, both of which are BRACE Award Venture Competition sponsors—and they themselves will NEVER sell, rent or otherwise convey the e-mail addresses to any other organization, without exception.